Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
6.86
+0.09 (1.33%)
Feb 4, 2026, 3:00 PM CST

SHA:600351 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
645.41578.59617.64668.5477.05350.41
Trading Asset Securities
8.96----0.1
Cash & Short-Term Investments
654.37578.59617.64668.5477.05350.51
Cash Growth
16.48%-6.32%-7.61%40.13%36.10%-27.69%
Accounts Receivable
417444.15601.32716.18667.79740.54
Other Receivables
43.143.9535.1470.5991.7263.68
Receivables
460.1488.1636.45786.77759.52804.21
Inventory
304.33413.05442.13449.14521.01498.01
Prepaid Expenses
-0.0100.03--
Other Current Assets
65.8179.5656.8149.939.5172.29
Total Current Assets
1,4851,5591,7531,9541,7971,725
Property, Plant & Equipment
1,1191,2031,3081,3771,4541,565
Long-Term Investments
372.31372.61377.72346.43314.68199.97
Goodwill
26.2726.2726.2726.2774.5774.57
Other Intangible Assets
140.27146.99154.96155.6157.39166.52
Long-Term Deferred Tax Assets
38.2241.8931.234.6128.4621.22
Long-Term Deferred Charges
89.13138.28155.8179.27146.35124.76
Other Long-Term Assets
72.5355.4646.6957.73104.03137.69
Total Assets
3,3433,5443,8544,1314,0774,014
Accounts Payable
116.21153.34191.7166.94120.66153.05
Accrued Expenses
50.5896.17123.09130.69111.71100.31
Short-Term Debt
5090.07200.22410.26502.37628.32
Current Portion of Long-Term Debt
--221.011.015.67
Current Portion of Leases
0.693.573.413.283.85-
Current Income Taxes Payable
39.694.076.3212.245.995.96
Current Unearned Revenue
52.0480.4467.32108.4890.245.45
Other Current Liabilities
164.14154.35191.4187.77169.62161.25
Total Current Liabilities
473.35582.02785.461,0411,0051,100
Long-Term Debt
50.03--22314
Long-Term Leases
0.682.063.375.18.52-
Long-Term Unearned Revenue
34.6137.2443.5347.9946.150.76
Long-Term Deferred Tax Liabilities
8.3899.269.9511.3612.46
Other Long-Term Liabilities
18.7218.7218.7218.7218.7218.72
Total Liabilities
585.77649.02860.331,1241,1131,196
Common Stock
700720770770770770
Additional Paid-In Capital
594.61703.76955.1955.32955.32955.32
Retained Earnings
1,5661,5611,4261,2651,2221,073
Treasury Stock
-38.88-66.06-150.45---
Comprehensive Income & Other
-25.7-25.7-24.41-20.01-20.05-20.02
Total Common Equity
2,7962,8932,9762,9702,9272,778
Minority Interest
-38.812.2817.1236.5636.6239.94
Shareholders' Equity
2,7572,8952,9933,0072,9642,818
Total Liabilities & Equity
3,3433,5443,8544,1314,0774,014
Total Debt
101.495.7209441.65538.74647.99
Net Cash (Debt)
552.96482.9408.64226.85-61.69-297.48
Net Cash Growth
18.85%18.17%80.14%---
Net Cash Per Share
0.780.670.540.29-0.08-0.39
Filing Date Shares Outstanding
700700720770770770
Total Common Shares Outstanding
700709.5748.7770770770
Working Capital
1,011977.3967.58913.67791.68625.03
Book Value Per Share
3.994.083.983.863.803.61
Tangible Book Value
2,6292,7192,7952,7882,6952,537
Tangible Book Value Per Share
3.763.833.733.623.503.30
Buildings
-1,6311,6131,5971,5451,538
Machinery
-1,3861,3601,3421,3401,324
Construction In Progress
-15.4957.4125.8326.4833.56
Source: S&P Global Market Intelligence. Standard template. Financial Sources.